Shenzhen Salubris Pharmaceuticals Co Ltd Free Cash Flow Generation Index
Shenzhen Salubris Pharmaceuticals Co Ltd free cash flow generation index. Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Free Cash Flow Generation Index of 0.27x as of September 2025. Free cash flow of CN¥108.45 Million represents 0% of operating cash flow (CN¥400.70 Million). Check 002294 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Free cash flow generation index of Shenzhen Salubris Pharmaceuticals Co Ltd from 2006 to 2024. Historical FCF Generation Index trend for Shenzhen Salubris Pharmaceuticals Co Ltd across 19 annual periods. Explore 002294 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Shenzhen Salubris Pharmaceuticals Co Ltd Free Cash Flow Generation Index by Year (2006–2024)
Shenzhen Salubris Pharmaceuticals Co Ltd free cash flow generation index by year from 2006 to 2024. Year-by-year Free Cash Flow Generation Index for Shenzhen Salubris Pharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Shenzhen Salubris Pharmaceuticals Co Ltd (002294) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.47x | CN¥561.45 Million | CN¥1.19 Billion | CN¥624.81 Million | ▲ +144.4% |
| 2023 | 0.19x | CN¥168.44 Million | CN¥869.79 Million | CN¥671.00 Million | ▼ -49.4% |
| 2022 | 0.38x | CN¥371.84 Million | CN¥970.80 Million | CN¥598.96 Million | ▼ -35.4% |
| 2021 | 0.59x | CN¥702.48 Million | CN¥1.18 Billion | CN¥482.50 Million | ▲ +11.3% |
| 2020 | 0.53x | CN¥731.86 Million | CN¥1.37 Billion | CN¥642.47 Million | ▼ -23.5% |
| 2019 | 0.70x | CN¥1.05 Billion | CN¥1.51 Billion | CN¥457.19 Million | ▼ -7.3% |
| 2018 | 0.75x | CN¥1.01 Billion | CN¥1.34 Billion | CN¥332.87 Million | ▼ -2.7% |
| 2017 | 0.77x | CN¥1.13 Billion | CN¥1.46 Billion | CN¥331.67 Million | ▼ -6.8% |
| 2016 | 0.83x | CN¥1.19 Billion | CN¥1.43 Billion | CN¥245.06 Million | ▲ +6.7% |
| 2015 | 0.78x | CN¥820.46 Million | CN¥1.06 Billion | CN¥235.57 Million | ▼ -2.4% |
| 2014 | 0.80x | CN¥781.59 Million | CN¥982.25 Million | CN¥200.65 Million | ▲ +120.4% |
| 2013 | 0.36x | CN¥241.32 Million | CN¥668.52 Million | CN¥427.20 Million | ▼ -19.8% |
| 2012 | 0.45x | CN¥234.46 Million | CN¥521.21 Million | CN¥286.75 Million | ▲ +521.2% |
| 2011 | 0.07x | CN¥19.72 Million | CN¥272.32 Million | CN¥252.60 Million | ▲ +136.7% |
| 2010 | -0.20x | CN¥-36.83 Million | CN¥186.65 Million | CN¥223.48 Million | ▼ -1799.6% |
| 2009 | -0.01x | CN¥-1.39 Million | CN¥134.28 Million | CN¥135.68 Million | ▼ -104.9% |
| 2008 | 0.21x | CN¥16.41 Million | CN¥77.89 Million | CN¥61.48 Million | ▼ -71.5% |
| 2007 | 0.74x | CN¥39.05 Million | CN¥52.75 Million | CN¥13.71 Million | ▲ +286.5% |
| 2006 | 0.19x | CN¥2.30 Million | CN¥12.00 Million | CN¥9.71 Million | — |